UCI chief wants investigation into Team Sky doping findings


AIGLE, Switzerland – The pinnacle of cycling’s globe governing entire body wishes an investigation in to the results of a doping report that accused Group Sky of using medications to enhance the overall performance of Bradley Wiggins and possibly other riders in advance from the 2012 Tour de France.

UCI President David Lappartient says he would really like his organization’s unbiased anti-doping division to “see when there is some violation of anti-doping policies.”

A British parliamentary committee mentioned inside a doping investigation report, printed on Monday, that Group Sky crossed an “ethical line” in 2012 by searching for a therapeutic use exemption for Wiggins to get a banned steroid “not to deal with professional medical require but to enhance his electric power to bodyweight ratio.”


Wiggins went on to gain the Tour de France that year.

Wiggins and Workforce Sky have both of those denied the accusations, indicating any treatment used was for respectable good reasons and inside UCI and Planet Anti-Doping Agency policies.

In an interview with all the BBC on Wednesday, Lappartient states the findings in the report “could impact the global reliability from the activity.”

Responding to Lappartient’s comments, Crew Sky reported it absolutely was “happy to co-operate with any investigation with the UCI and we might welcome even further scrutiny of the select committee’s report.”

A workforce assertion mentioned: “While we’ve acknowledged past failings, we strongly deny the extremely significant new allegations in regards to the usage of medication to improve overall performance, as does Bradley Wiggins.

“Furthermore, we have been anxious which the committee offered these unsubstantiated allegations without furnishing evidence to help them, which is essentially unfair on the team and its riders. We welcome any assessment via the UCI which may support build the character on the proof relied on by the committee in coming to its conclusions.”


Please enter your comment!
Please enter your name here